Vernalis Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 80

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 10

  • Investments
  • 6

Vernalis General Information

Description

Developer of bio-medical products created for the treatment of several diseases based in Cambridge, United Kingdom. The company's research laboratories integrate fragment-based approaches, structural biology, biophysics, assay technology and molecular modeling with extensive medicinal chemistry expertise, thereby enabling drug discovery on both established and novel targets.

Contact Information

Formerly Known As
Vanguard Medica
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Granta Park Great Abington
  • Cambridge CB21 6GB
  • England, United Kingdom
+44 01223
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • Granta Park Great Abington
  • Cambridge CB21 6GB
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vernalis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vernalis‘s full profile, request access.

Request a free trial

Vernalis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bio-medical products created for the treatment of several diseases based in Cambridge, United Kingdom. The
Biotechnology
Cambridge, United Kingdom
80 As of 2020

Cambridge, United Kingdom
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vernalis Competitors (42)

One of Vernalis’s 42 competitors is Mission Therapeutics, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mission Therapeutics Venture Capital-Backed Cambridge, United Kingdom
Metrion Biosciences Venture Capital-Backed Cambridge, United Kingdom
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Aviva Systems Biology Formerly VC-backed San Diego, CA
You’re viewing 5 of 42 competitors. Get the full list »

Vernalis Patents

Vernalis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026229590-A1 Polycyclic derivatives, pharmaceutical compositions containing them, their combination with one or more anti-cancer agents, and their uses as pro-apoptotic agents Pending 30-Apr-2025
AU-2025254981-A1 New amide derivatives, pharmaceutical compositions containing them and their uses as sos1 inhibitors Pending 10-Apr-2024
WO-2025215110-A1 New amide derivatives, pharmaceutical compositions containing them and their uses as sos1 inhibitors Pending 10-Apr-2024
AU-2025213763-A1 New amide derivatives, pharmaceutical compositions containing them and their uses as sos1 inhibitors Pending 31-Jan-2024
WO-2025163050-A1 New amide derivatives, pharmaceutical compositions containing them and their uses as sos1 inhibitors Pending 31-Jan-2024 C07D405/14
To view Vernalis’s complete patent history, request access »

Vernalis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vernalis Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vernalis‘s full profile, request access.

Request a free trial

Vernalis Investments & Acquisitions (6)

Vernalis’s most recent deal was a Seed Round with Unison Medicines. The deal was made on 09-Mar-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Unison Medicines 09-Mar-2022 Seed Round Drug Discovery
Dania Therapeutics 31-Oct-2021 Joint Venture Drug Discovery
Cita NeuroPharmaceutical 18-Nov-2005 Merger/Acquisition Biotechnology
Pintex Pharmaceuticals 01-Apr-2005 Merger/Acquisition Pharmaceuticals
British Biotech 03-Jul-2003 Merger/Acquisition Other Pharmaceuticals and Biotechnology
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Vernalis FAQs

  • When was Vernalis founded?

    Vernalis was founded in 1986.

  • Where is Vernalis headquartered?

    Vernalis is headquartered in Cambridge, United Kingdom.

  • What is the size of Vernalis?

    Vernalis has 80 total employees.

  • What industry is Vernalis in?

    Vernalis’s primary industry is Biotechnology.

  • Is Vernalis a private or public company?

    Vernalis is a Private company.

  • What is the current valuation of Vernalis?

    The current valuation of Vernalis is .

  • What is Vernalis’s current revenue?

    The current revenue for Vernalis is .

  • How much funding has Vernalis raised over time?

    Vernalis has raised $195M.

  • Who are Vernalis’s investors?

    Apax Nominees, BVF Partners, Domain Associates, HarbourVest Partners, and Invesco are 5 of 12 investors who have invested in Vernalis.

  • Who are Vernalis’s competitors?

    Mission Therapeutics, Metrion Biosciences, Sygnature Discovery, Genetix Biotherapeutics, and Aviva Systems Biology are some of the 42 competitors of Vernalis.

  • When was Vernalis acquired?

    Vernalis was acquired on 02-Dec-2020.

  • Who acquired Vernalis?

    Vernalis was acquired by HitGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process